These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 33913818)

  • 21. Efficacy of Integrating the Management of Pain and Addiction via Collaborative Treatment (IMPACT) in Individuals With Chronic Pain and Opioid Use Disorder: Protocol for a Randomized Clinical Trial of a Digital Cognitive Behavioral Treatment.
    MacLean RR; Ankawi B; Driscoll MA; Gordon MA; Frankforter TL; Nich C; Szollosy SK; Loya JM; Brito L; Ribeiro MIP; Edmond SN; Becker WC; Martino S; Sofuoglu M; Heapy AA
    JMIR Res Protoc; 2024 Mar; 13():e54342. PubMed ID: 38506917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term treatment retention of an emergency department initiated medication for opioid use disorder program.
    Reuter QR; Santos AD; McKinnon J; Gothard D; Jouriles N; Seaberg D
    Am J Emerg Med; 2022 May; 55():98-102. PubMed ID: 35304308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of a Peer-Led Behavioral Intervention for Emergency Department Patients at High Risk of Fatal Opioid Overdose: A Randomized Clinical Trial.
    Beaudoin FL; Jacka BP; Li Y; Samuels EA; Hallowell BD; Peachey AM; Newman RA; Daly MM; Langdon KJ; Marshall BDL
    JAMA Netw Open; 2022 Aug; 5(8):e2225582. PubMed ID: 35943744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results From the POINT Pragmatic Randomized Trial: An Emergency Department-Based Peer Support Specialist Intervention to Increase Opioid Use Disorder Treatment Linkage and Reduce Recurrent Overdose.
    Watson DP; Tillson M; Taylor L; Xu H; Ouyang F; Beaudoin FL; O'Donnell D; McGuire AB
    Subst Use Addctn J; 2024 Jul; 45(3):378-389. PubMed ID: 38258819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementation of buprenorphine initiation and warm handoff protocols in emergency departments: A qualitative study of Pennsylvania hospitals.
    Patel E; Solomon K; Saleem H; Saloner B; Pugh T; Hulsey E; Leontsini E
    J Subst Abuse Treat; 2022 May; 136():108658. PubMed ID: 34774397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ensuring buprenorphine access in rural community pharmacies to prevent overdoses.
    Ostrach B; Potter R; Wilson CG; Carpenter D
    J Am Pharm Assoc (2003); 2022; 62(2):588-597.e2. PubMed ID: 34674965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation facilitation to introduce and support emergency department-initiated buprenorphine for opioid use disorder in high need, low resource settings: protocol for multi-site implementation-feasibility study.
    McCormack RP; Rotrosen J; Gauthier P; D'Onofrio G; Fiellin DA; Marsch LA; Novo P; Liu D; Edelman EJ; Farkas S; Matthews AG; Mulatya C; Salazar D; Wolff J; Knight R; Goodman W; Hawk K
    Addict Sci Clin Pract; 2021 Mar; 16(1):16. PubMed ID: 33750454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergency Department Peer Support Program and Patient Outcomes After Opioid Overdose.
    Treitler P; Crystal S; Cantor J; Chakravarty S; Kline A; Morton C; Powell KG; Borys S; Cooperman NA
    JAMA Netw Open; 2024 Mar; 7(3):e243614. PubMed ID: 38526490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Buprenorphine use and disparities in access among emergency department patients with opioid use disorder: A cross-sectional study.
    Robbins M; Haroz R; Mazzarelli A; Clements D; Jones CW; Salzman M
    J Subst Abuse Treat; 2021 Nov; 130():108405. PubMed ID: 34118697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and Implementation of a Curriculum for Emergency Medicine Residents to Address Medications and Treatment Referral for Opioid Use Disorder.
    Walter LA; Hess J; Brown M; DeLaney M; Paddock C; Hess EP
    Subst Use Misuse; 2021; 56(4):458-463. PubMed ID: 33587018
    [No Abstract]   [Full Text] [Related]  

  • 31. Association of Medicaid Expansion With Opioid Overdose Mortality in the United States.
    Kravitz-Wirtz N; Davis CS; Ponicki WR; Rivera-Aguirre A; Marshall BDL; Martins SS; Cerdá M
    JAMA Netw Open; 2020 Jan; 3(1):e1919066. PubMed ID: 31922561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recovery opioid overdose team (ROOT) pilot program evaluation: A community-wide post-overdose response strategy.
    Dahlem CHG; Scalera M; Anderson G; Tasker M; Ploutz-Snyder R; McCabe SE; Boyd CJ
    Subst Abus; 2021; 42(4):423-427. PubMed ID: 33284095
    [No Abstract]   [Full Text] [Related]  

  • 33. Feasibility and acceptability of electronic administration of patient reported outcomes using mHealth platform in emergency department patients with non-medical opioid use.
    Hawk K; Malicki C; Kinsman J; D'Onofrio G; Taylor A; Venkatesh A
    Addict Sci Clin Pract; 2021 Nov; 16(1):66. PubMed ID: 34758881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial.
    Molfenter T; Knudsen HK; Brown R; Jacobson N; Horst J; Van Etten M; Kim JS; Haram E; Collier E; Starr S; Toy A; Madden L
    Implement Sci; 2017 Nov; 12(1):135. PubMed ID: 29141653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interrupted Time Series Analysis: Patient Characteristics and Rates of Opioid-Use-Disorder-Related Emergency Department Visits in the Los Angeles County Public Hospital System during COVID-19.
    Johnson E; Axeen S; Vosooghi A; Lam CN; Bluthenthal R; Schneberk T
    Healthcare (Basel); 2023 Mar; 11(7):. PubMed ID: 37046906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergency Department Clinicians' Attitudes Toward Opioid Use Disorder and Emergency Department-initiated Buprenorphine Treatment: A Mixed-Methods Study.
    Im DD; Chary A; Condella AL; Vongsachang H; Carlson LC; Vogel L; Martin A; Kunzler N; Weiner SG; Samuels-Kalow M
    West J Emerg Med; 2020 Feb; 21(2):261-271. PubMed ID: 32191184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Demographics and Clinical Characteristics of Patients With Opioid Use Disorder and Offered Medication-Assisted Treatment in the Emergency Department.
    Fu W; Adzhiashvili V; Majlesi N
    Cureus; 2023 Jul; 15(7):e41464. PubMed ID: 37546079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department.
    Wiercigroch D; Hoyeck P; Sheikh H; Hulme J
    BMC Emerg Med; 2021 Apr; 21(1):48. PubMed ID: 33858328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Buprenorphine/naloxone induction in a Canadian emergency department with rapid access to community-based addictions providers.
    Hu T; Snider-Adler M; Nijmeh L; Pyle A
    CJEM; 2019 Jul; 21(4):492-498. PubMed ID: 31006398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementing a Novel Statewide Network to Support Emergency Department-initiated Buprenorphine Treatment.
    Clemency BM; Hoopsick RA; Burnett SJ; Kahn LS; Lynch JJ
    West J Emerg Med; 2022 Jun; 23(4):451-460. PubMed ID: 35980408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.